Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
116.27
187.10
237.29
861.47
1,058.80
1,315.17
1,185.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
116.27
187.10
237.29
861.47
1,058.80
1,315.17
1,185.66
Raw Material Cost
57.76
109.95
153.00
356.56
483.24
561.91
489.80
Purchase of Finished goods
0.00
0.80
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
2.09
160.76
0.48
-2.04
-20.69
-43.51
-10.13
Employee Cost
28.39
32.67
36.22
195.66
233.36
241.76
197.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
0.00
296.21
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
41.08
70.22
55.65
287.50
354.78
377.87
-0.00
Total Expenditure (Excl Depreciation)
129.32
374.40
245.35
837.69
1,050.69
1,138.03
973.66
Operating Profit (PBDIT) excl Other Income
-13.05
-187.30
-8.06
23.78
8.11
177.14
212.00
Other Income
4.37
0.97
1.27
9.82
8.26
22.96
9.61
Operating Profit (PBDIT)
-8.68
-186.33
-6.79
33.60
16.37
200.10
221.61
Interest
2.95
35.90
39.76
53.88
58.89
67.26
79.48
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-11.63
-222.23
-46.55
-20.28
-42.52
132.84
142.13
Depreciation
20.22
108.41
18.28
55.49
66.95
66.79
56.42
Profit Before Tax
-31.85
-330.65
-64.83
-75.77
-109.47
66.05
85.71
Tax
0.11
-2.12
2.82
2.03
-0.36
8.68
9.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-31.96
-328.53
-67.65
-77.80
-109.12
57.37
76.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-31.96
-328.53
-67.65
-77.80
-109.12
57.37
76.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
1.85
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-31.96
-328.53
-67.65
-77.80
-109.12
57.37
77.94
Equity Capital
16.58
16.58
16.58
16.58
16.58
16.50
16.51
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
-51.75
22.84
347.70
414.99
492.79
0.00
884.67
Earnings per share (EPS)
-3.86
-39.63
-8.16
-9.38
-13.16
6.95
9.44
Diluted Earnings per share
-3.74
-38.46
-7.92
-9.11
-12.77
6.67
9.21
Operating Profit Margin (Excl OI)
-11.22%
-100.11%
-3.4%
2.76%
0.77%
13.47%
17.88%
Gross Profit Margin
-10.0%
-118.78%
-19.62%
-2.35%
-4.02%
10.1%
11.99%
PAT Margin
-27.49%
-175.59%
-28.51%
-9.03%
-10.31%
4.36%
6.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -37.86% vs -21.15% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 90.27% vs -385.63% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 93.03% vs -2,223.82% in Mar 2023
Interest
YoY Growth in year ended Mar 2025 is -91.78% vs -9.71% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2023
Compare Annual Results Of Vivimed Labs. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
116.27
32,553.50
-32,437.23
-99.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
116.27
32,553.50
-32,437.23
-99.64%
Raw Material Cost
57.76
14,505.40
-14,447.64
-99.60%
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
2.09
0
2.09
Employee Cost
28.39
5,580.00
-5,551.61
-99.49%
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
282.90
-282.90
-100.00%
Selling and Distribution Expenses
0.00
8,526.90
-8,526.90
-100.00%
Other Expenses
41.08
-3,259.50
3,300.58
101.26%
Total Expenditure (Excl Depreciation)
129.32
25,635.70
-25,506.38
-99.50%
Operating Profit (PBDIT) excl Other Income
-13.05
6,917.80
-6,930.85
-100.19%
Other Income
4.37
1,158.80
-1,154.43
-99.62%
Operating Profit (PBDIT)
-8.68
9,814.70
-9,823.38
-100.09%
Interest
2.95
282.90
-279.95
-98.96%
Exceptional Items
0.00
-169.30
169.30
100.00%
Gross Profit (PBDT)
-11.63
18,048.10
-18,059.73
-100.06%
Depreciation
20.22
1,705.80
-1,685.58
-98.81%
Profit Before Tax
-31.85
7,656.70
-7,688.55
-100.42%
Tax
0.11
1,953.90
-1,953.79
-99.99%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-31.96
5,654.40
-5,686.36
-100.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-31.96
5,654.40
-5,686.36
-100.57%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
70.10
-70.10
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-31.96
5,724.50
-5,756.46
-100.56%
Equity Capital
16.58
0
16.58
Face Value
2.00
1.00
0.00
Reserves
-51.75
33,338.80
-33,390.55
-100.16%
Earnings per share (EPS)
-3.86
67.78
-71.64
-105.69%
Diluted Earnings per share
-3.74
67.78
-71.52
-105.52%
Operating Profit Margin (Excl OI)
-11.22%
21.35%
0.00
-32.57%
Gross Profit Margin
-10.00%
28.76%
0.00
-38.76%
PAT Margin
-27.49%
17.37%
0.00
-44.86%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 116.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -37.86% vs -21.15% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -31.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 90.27% vs -385.63% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -13.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 93.03% vs -2,223.82% in Mar 2023
Annual - Interest
Interest 2.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -91.78% vs -9.71% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -11.22%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
